Management of male osteoporosis

Joint Bone Spine

Volumn 68, Issue 3, 2001, Pages 252-256

  Cortet, Bernard ^a   Vasseur, Jacques ^a   Grardel, Bruno ^a   Catanzariti, Lionel ^a   Marchandise, Xavier ^a   Delcambre, Bernard ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Bisphosphonate; Bone mineral density; Calcitriol; Calcium; Male osteoporosis; Vitamin D

Indexed keywords

CALCITRIOL; CALCIUM; ETIDRONIC ACID; HYDROCHLOROTHIAZIDE; PHOSPHATE; TESTOSTERONE; VITAMIN D;

ADULT; ARTICLE; BONE DENSITY; DIABETES MELLITUS; FRACTURE; GASTROINTESTINAL DISEASE; HUMAN; HYPERCALCIURIA; HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; SUPPLEMENTATION;

EID: 0034999184     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(01)00272-X     Document Type: Article

References (14)

1. Melton L.J. III, Chrischilles E.A., Cooper C., Lane A.W., Riggs B.L. How many women have osteoporosis? J Bone Miner Res. 7:1992;1005-1110.
2. Legroux-Gérot I., Blanckaert F., Solau-Gervais E., Negahban M., Duquesnoy B., Delcambre B., et al. Causes of osteoporosis in males. 160 patients. Rev Rhum Engl Ed 66:1999;404-409.
3. Melton L.J. III, Atkinson E.J., O'Connor M.K., O'Fallon W.M., Riggs B.L. Bone density and fracture risk in men. J Bone Miner Res. 13:1998;1915-1923.
4. Legrand E., Chappard D., Pascaretti C., Duquenne M., Rondeau C., Simon Y., et al. Bone mineral density and vertebral fractures in men. Osteoporos Int. 10:1999;265-270.
5. Orme S.M., Simpson M., Stewart S.P., Oldroyd B., Westmacott C.F., Smith M.A., et al. Comparison of changes in bone mineral density in idiopathic and secondary osteoporosis following therapy with cyclical disodium etidronate and high dose calcium supplementation. Clin Endocrinol. 41:1994;245-250.
6. Geusens P., Vanhoof J., Raus J., Dequeker J., Nijs J., Joly J. Treatment with etidronate for men with idiopathic osteoporosis. Ann Rheum Dis. 56:1999;280-280.
7. Laroche M., Constantin A., Andrieu V., Mazières B. Beneficial effect on bone density in male osteoporosis of postmenopausal osteoporosis treatment (Fluoride, Etidronate, and Calcitriol). Clin Exp Rheumatol. 16:1998;760-760.
8. Orwoll E., Ettinger M., Weiss S., Miller P., Kendler D., Graham J., et al. Alendronate for the treatment of osteoporosis in men. N Engl J M. 343:2000;604-610.
9. Amor B., Clemente-Coelho P.J., Roux C. Adult-onset idiopathic phosphate diabetes. II. Time-course of clinical laboratory test and bone mineral density abnormalities under combined phosphate and calcitriol therapy. Rev Rhum Ed Engl. 62:1995;183-188.
10. Anderson F.H., Francis R.M., Peaston R.T., Wastell H.J. Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption. J Bone Miner Res. 12:1997;472-478.
11. Kenny A.M., Prestwood K.M., Marcell K.D., Fall P.M., Raisz L.G. The effects of transdermal testosterone on bone mineral density (BMD), bone turnover markers and muscle strength in older men abstract J Bone Miner Res. 14 Suppl 1:1999;184-184.
12. Orwoll E.S., Oviatt S.K., McClung M.R., Deftos L.J., Sexton G. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Intern M. 112:1990;29-34.
13. Dawson-Hughes B., Harris S., Krall E.A., Dallal G. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J M. 337:1997;670-676.
14. Adams J.S., Song C.F., Kantorovich V. Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide. Ann Intern M. 130:1999;658-660.